Brokerages expect Axcelis Technologies Inc (NASDAQ:ACLS) to announce $99.70 million in sales for the current fiscal quarter, Zacks Investment Research reports. Three analysts have issued estimates for Axcelis Technologies’ earnings. The highest sales estimate is $100.00 million and the lowest is $99.10 million. Axcelis Technologies posted sales of $116.40 million in the same quarter last year, which would indicate a negative year-over-year growth rate of 14.3%. The business is expected to announce its next quarterly earnings results on Tuesday, February 5th.

According to Zacks, analysts expect that Axcelis Technologies will report full year sales of $436.57 million for the current fiscal year, with estimates ranging from $436.00 million to $436.90 million. For the next fiscal year, analysts forecast that the business will report sales of $455.23 million, with estimates ranging from $440.70 million to $470.00 million. Zacks Investment Research’s sales calculations are an average based on a survey of research firms that cover Axcelis Technologies.

Axcelis Technologies (NASDAQ:ACLS) last announced its quarterly earnings results on Thursday, November 1st. The semiconductor company reported $0.22 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.05. The company had revenue of $95.40 million for the quarter, compared to the consensus estimate of $97.82 million. Axcelis Technologies had a return on equity of 13.86% and a net margin of 28.48%. The firm’s revenue for the quarter was down 8.7% compared to the same quarter last year. During the same period last year, the firm earned $0.35 EPS.

A number of equities research analysts have recently commented on the company. BidaskClub upgraded Axcelis Technologies from a “sell” rating to a “hold” rating in a research report on Thursday, October 18th. ValuEngine upgraded Axcelis Technologies from a “sell” rating to a “hold” rating in a research report on Saturday, December 1st. Benchmark cut Axcelis Technologies from a “buy” rating to a “hold” rating in a research report on Friday, November 2nd. Zacks Investment Research upgraded Axcelis Technologies from a “strong sell” rating to a “hold” rating in a research report on Thursday, January 3rd. Finally, B. Riley cut Axcelis Technologies from a “buy” rating to a “neutral” rating and dropped their target price for the company from $34.00 to $20.00 in a research report on Monday, October 29th. Five research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Axcelis Technologies has a consensus rating of “Hold” and an average price target of $27.00.

ACLS traded up $0.62 during midday trading on Friday, hitting $18.73. 4,262 shares of the company were exchanged, compared to its average volume of 216,262. The company has a market capitalization of $585.69 million, a P/E ratio of 12.79 and a beta of 1.03. Axcelis Technologies has a 1-year low of $15.46 and a 1-year high of $31.00.

In related news, Director John T. Kurtzweil sold 2,500 shares of Axcelis Technologies stock in a transaction dated Wednesday, November 21st. The stock was sold at an average price of $17.61, for a total value of $44,025.00. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 3.31% of the company’s stock.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc grew its stake in shares of Axcelis Technologies by 0.5% in the third quarter. Vanguard Group Inc now owns 1,957,527 shares of the semiconductor company’s stock worth $38,465,000 after acquiring an additional 10,175 shares in the last quarter. Marshall Wace LLP acquired a new position in shares of Axcelis Technologies in the third quarter worth $1,333,000. Vanguard Group Inc. grew its stake in shares of Axcelis Technologies by 0.5% during the third quarter. Vanguard Group Inc. now owns 1,957,527 shares of the semiconductor company’s stock worth $38,465,000 after purchasing an additional 10,175 shares in the last quarter. Morgan Stanley grew its stake in shares of Axcelis Technologies by 19.2% during the third quarter. Morgan Stanley now owns 90,680 shares of the semiconductor company’s stock worth $1,783,000 after purchasing an additional 14,630 shares in the last quarter. Finally, Legal & General Group Plc grew its stake in shares of Axcelis Technologies by 8.5% during the third quarter. Legal & General Group Plc now owns 68,984 shares of the semiconductor company’s stock worth $1,353,000 after purchasing an additional 5,418 shares in the last quarter. 80.59% of the stock is currently owned by institutional investors and hedge funds.

Axcelis Technologies Company Profile

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips worldwide. The company offers a line of high energy, high current, and medium current implanters for various application requirements. It also provides dry strip equipment, curing systems, and thermal processing systems.

Featured Article: What is a stock split?

Get a free copy of the Zacks research report on Axcelis Technologies (ACLS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Axcelis Technologies (NASDAQ:ACLS)

Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.